RFK Jr.'s appointment as HHS Secretary is creating pressure as Medicare price setting and Part D redesign impact the sales and operations of major pharmaceutical companies including Pfizer, Amgen, J&J, Merck, and Eli Lilly.

The entities involved

• Robert F. Kennedy Jr. →

  American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)

  • Trump is noted for recycling political tactics, including using Islamophobia against opponents like El-Sayed, while political commentators observe his divisive style.13:24
  • HHS policy allows peptides in compounding pharmacies despite FDA lack of approval, with RFK Jr. arguing for safer compounds.08:58
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • PepsiCo, Meta, Toyota, Google, and Pfizer contributed founding council members to the Peerworks initiative led by Zero100.10:24
  • Pfizer's plant in Gujarat, which supplies chemotherapy drugs, suffered flood damage.08:24
• Amgen →

  American multinational biopharmaceutical company

  • Amgen and Google stock movements offset each other on October 29, 2026.Thu 17:55
  • Peter Griffith serves as the Chief Financial Officer at Amgen.Thu 12:02
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • CRISPR Therapeutics, Eli Lilly, and Johnson & Johnson are noted as major holdings in health care ETFs.17:44
  • Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.Thu 23:00

Related events

• Robert F. Kennedy Jr. served as health secretary for HHS and was involved in FDA leadership decisions.Jun 12
• RFK Jr. praised Trump's administration regarding drug pricing policy, while Trump used Biden's administration as a political contrast.Sep 2
• The HHS Secretary has cut chronic disease programs.Oct 21